| Mobile Web

Search results for drug development

Industry

MSIT steps up \'K-Moonshot\' AI drug mission with stakeholder meeting

South Korea\'s Ministry of Science and ICT held a meeting on Sunday at Catholic University to collect opinions on the K-Moonshot AI drug mission. The event brought together experts from industry, academia, research institutes and hospitals to share the project direction ahead of its full rollout. The national R&D project aims to apply AI across drug development, including candidate discovery, drug design and efficacy and toxicity prediction, shifting to an AI-based design approach.

AI & Enterprise

SK Telecom, SK Biopharm find early drug candidates for hard-to-treat cancer with AI

SK Telecom and SK Biopharm have discovered early-stage drug candidates that could be used to develop targeted therapies for hard-to-treat cancers using AI. The companies said they generated and selected binder candidates that can attach to ROR1, a tumour-related cell surface protein, and confirmed 2 early candidates through laboratory validation. The joint study took about 5 months and cut the early research period by more than 60 percent.

People

Vice minister Goo reviews national new drug development results, says AI will speed innovation

Goo Hyeok-chae (구혁채), first vice minister at South Korea\'s Ministry of Science and ICT, held a meeting on Monday at the National New Drug Development Project unit in Seoul to hear strategies for generating results from the unit and supported companies. The visit marked the 21st step in the government’s Project Empathy 118 initiative for field-focused science and technology policy. Goo said the programme would strengthen performance-based support in phase two and actively use AI.